PressDigest

Teva weighs Mylan bid to disrupt Perrigo deal

Teva Pharmaceutical Industries, the Israeli generic drug maker, is weighing a takeover offer for rival Mylan to thwart the latter’s proposed $28.9bn acquisition of Ireland-based Perrigo, The Wall Street Journal has learnt.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump